Next Article in Journal
Synthesis and Biological Activity of 5-Aminopyrimidineterpenes
Previous Article in Journal
Constituents from the leaves of Crataegus davisii Browicz
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development of bioadhesive chitosan gels for topical delivery of lidocaine

by
Jaleh Varshosaz
1,*,
Fariba Jaffari
2 and
Sara Karimzadeh
1
1
Department of Pharmaceutics, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
2
Department of Pharmacology, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
*
Author to whom correspondence should be addressed.
Submission received: 5 April 2006 / Accepted: 8 August 2006 / Published: 30 December 2006

Abstract

Lidocaine (LC) is a local anesthetic agent. The aim of this study is prolonging the anesthetic effect of this drug for transdermal delivery. Gels of LC hydrochloride were prepared with three different molecular weights (MW) and concentrations of chitosan. lecithin was used as permeation enhancer. Viscosity, bioadhesion, drug release from synthetic membranes, drug permeation through the biological barrier (rat skin) and antinocicetive effect of gels were studied. Increasing the concentration of chitosan caused to decrease the bioadhesion. Drug release studies in gels showed that increasing the concentration and MW of chitosan caused an increase in both the rate and extent and also in flux of drug probably because of the increase in repulsive forces between LC and chitosan cations. The flux of drug through the rat skin was higher for 3% high MW chitosan gel (H3) compared to the standard gel. LC was effective topically in hind paw formalin assay. It was most active immediately after its administration. The analgesic activity of LC in H3 gel could cover the duration of the formalin nociception. The maximal response of LC in comparable doses of H3 and standard gel was about 52% and 36% analgesia in the second phase, respectively compared to the control group. The higher response of the H3 gel may be attributed to the bioadhesive effect of chitosan base and the higher concentrations of LC compared to the standard gel.
Keywords: Lidocaine; Chitosan gel; antinociception; transdermal delivery Lidocaine; Chitosan gel; antinociception; transdermal delivery

Share and Cite

MDPI and ACS Style

Varshosaz, J.; Jaffari, F.; Karimzadeh, S. Development of bioadhesive chitosan gels for topical delivery of lidocaine. Sci. Pharm. 2006, 74, 209-223. https://0-doi-org.brum.beds.ac.uk/10.3797/scipharm.2006.74.209

AMA Style

Varshosaz J, Jaffari F, Karimzadeh S. Development of bioadhesive chitosan gels for topical delivery of lidocaine. Scientia Pharmaceutica. 2006; 74(4):209-223. https://0-doi-org.brum.beds.ac.uk/10.3797/scipharm.2006.74.209

Chicago/Turabian Style

Varshosaz, Jaleh, Fariba Jaffari, and Sara Karimzadeh. 2006. "Development of bioadhesive chitosan gels for topical delivery of lidocaine" Scientia Pharmaceutica 74, no. 4: 209-223. https://0-doi-org.brum.beds.ac.uk/10.3797/scipharm.2006.74.209

Article Metrics

Back to TopTop